New Drugs Should Be Compared To Current Treatments Before Approval

September 12, 2011

Today on bmj.com researchers argue that, before approval, manufactures should have to reveal how their medicine compares to treatments that already exist, in order to make sure that the most effective and safest treatments reach patients and that limited healthcare resources are invested wisely. (Medical News Today)